Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10007669HBVENSG00000118520.16protein_codingARG1NoNo383P05089
TVIS10062719HBVENSG00000118520.16protein_codingARG1NoNo383P05089
TVIS30077929HIVENSG00000118520.16protein_codingARG1NoNo383P05089
TVIS30020841HIVENSG00000118520.16protein_codingARG1NoNo383P05089
TVIS20061167HPVENSG00000118520.16protein_codingARG1NoNo383P05089
TVIS44030148HTLV-1ENSG00000118520.16protein_codingARG1NoNo383P05089
TVIS44003144HTLV-1ENSG00000118520.16protein_codingARG1NoNo383P05089
TCGA Plot Options
Drug Information
GeneARG1
DrugBank IDDB00129
Drug NameOrnithine
Target IDBE0000286
UniProt IDP05089
Regulation Type
PubMed IDs11971019; 12135320; 12446178; 12589193; 12679340
CitationsGobert AP, Cheng Y, Wang JY, Boucher JL, Iyer RK, Cederbaum SD, Casero RA Jr, Newton JC, Wilson KT: Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol. 2002 May 1;168(9):4692-700.@@Iwata S, Tsujino T, Ikeda Y, Ishida T, Ueyama T, Gotoh T, Mori M, Yokoyama M: Decreased expression of arginase II in the kidneys of Dahl salt-sensitive rats. Hypertens Res. 2002 May;25(3):411-8.@@Stickings P, Mistry SK, Boucher JL, Morris SM, Cunningham JM: Arginase expression and modulation of IL-1beta-induced nitric oxide generation in rat and human islets of Langerhans. Nitric Oxide. 2002 Dec;7(4):289-96.@@Bansal V, Ochoa JB: Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care. 2003 Mar;6(2):223-8.@@El Alami M, Dubois E, Oudjama Y, Tricot C, Wouters J, Stalon V, Messenguy F: Yeast epiarginase regulation, an enzyme-enzyme activity control: identification of residues of ornithine carbamoyltransferase and arginase responsible for enzyme catalytic and regulatory activities. J Biol Chem. 2003 Jun 13;278(24):21550-8. Epub 2003 Apr 4.
GroupsApproved; Nutraceutical
Direct ClassificationL-alpha-amino acids
SMILESNCCC[C@H](N)C(O)=O
PathwaysCitrullinemia Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Argininemia; Hyperornithinemia with Gyrate Atrophy (HOGA); Spermidine and Spermine Biosynthesis; Hyperprolinemia Type II; Argininosuccinic Aciduria; L-Arginine:Glycine Amidinotransferase Deficiency; Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency; Carbamoyl Phosphate Synthetase Deficiency; Ornithine Aminotransferase Deficiency (OAT Deficiency); Hyperprolinemia Type I; Arginine and Proline Metabolism; Ornithine Transcarbamylase Deficiency (OTC Deficiency); Prolinemia Type II; Urea Cycle
PharmGKBPA164783814
ChEMBLCHEMBL446143